Sign In
|
|
Free Newsletters
Finance Resource Center
D&B Credit Reports
Businesses for Sale
What's Your Credit Emergency?
Thriving in Tough Times
Trade Magazines
Home
Topics
Bloggers
Franchises
Videos
Podcasts
Library
Ask the Experts
Shop Legal Forms
Find Vendors
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Careers
|
Green Business
|
Starting a Business
|
Sales & Selling
|
Business Credit
|
Women in Business
|
Web Tools
|
Company Profiles
Business Travel
|
Manufacturing
|
Retail
|
Sales
|
Starting a Business
|
Technology
|
> See All Topics
|
> See All Industries
Business Intelligence
|
Small Business Blog
|
Finance
|
Operations
|
Sales
|
Technology
|
> See All
AllBusiness AllStars
|
Franchise Directory
|
Buying a Franchise
|
Growing Your Franchise
|
Franchising Your Business
Human Resources
|
Franchises
|
Manufacturing
|
Marketing & Advertising
|
Sales
|
Technology
|
> See All
Finance
|
Green Business
|
Sales
|
Starting a Company
|
Technology
|
Women in Business
|
> See All
Professional Journals
|
Business Answers
|
Company Profiles
|
Glossary
Business Travel
|
Entrepreneurship
|
Finance
|
Franchising
|
Inventing
|
Sales
|
B2B Sales
Form Kits
|
Letter of Intent
|
Web Sites
|
Confidentiality
|
Employment
|
Consulting
|
Due Diligence
|
Demand Letters
|
Business Guides
> See All
Business Directory
|
Quote Center
|
Partner Resources
Protein Based Drugs
The best tips and advice from our vast library of articles, videos, and business tools
Browse Related Topics
Pharmaceutical Agents & Products
Pharmaceuticals & Biotechnology
Tools
Businesses for Sale
Business Cash Advance
Business Directory
Lead Lists
Free Magazines
Free Industry Resources
Newly Added Articles
Sales sparked by fears of Christmas slump
Private equity dealmakers still alive and well
More moving into county than out, reversing trend
Tight supply or oversupply? Speculation abound in...
Windows Dressing: Fixing Vista's Image; Microsoft...
The Palm Beach Post, Fla., Jeff Ostrowski column
SMALL BUSINESS
Search Results
1-20
of 947 related articles
Best Of
Past 30 Days
This Year
Past 5 Years
All Dates
Biolex Raises $30M In Series C To Advance Hepatitis C Drug.
Staff Writer Awaiting data from an ongoing Phase II trial of Locteron, a controlled-release interferon-alpha candidate for hepatitis...
unaggregatedarticle
Ambrx Raises $23M Privately To Advance Growth Hormone.
Staff Writer Ambrx Inc. completed its second private placement, raising $23.4 million to advance its first product, a...
unaggregatedarticle
Viropro Signs First Major Technology Transfer Deal.
Senior Staff Writer Viropro Inc. - a company that serves as a bridge between therapeutic proteins and developing...
unaggregatedarticle
Other News To Note.
Abgenix Inc., of Fremont, Calif., entered a collaboration with U3 Pharma AG, of Martinsried, Germany, for fully human...
unaggregatedarticle
A Different Type Of Off-Shoring To Produce Therapeutic Proteins.
Science Editor From Genentech Inc. 's Avastin to Biogen Idec Inc. 's Zevalin, nearly twenty FDA-approved monoclonal antibodies...
unaggregatedarticle
Research from Novo Nordisk provide new insights into monoclonal antibodies.
According to a study from Denmark, "Inhibitory-cell killer immunoglobulin-like receptors (KIR) negatively regulate natural killer (NK) cell-mediated killing...
unaggregatedarticle
Cancer Researchers Continue Radioimmunotherapy Exploration.
BioWorld International Correspondent SAN FRANCISCO - Parallel advances in the therapeutic uses of monoclonal antibodies and the discovery...
unaggregatedarticle
Crucell Signs Up Another PER.C6 Customer, Enters Deal With GSK.
Staff Writer When it's not focusing on developing vaccines and antibodies against infectious diseases, Crucell NV leverages its...
unaggregatedarticle
AVILA PRESENTS DATA ON ITS NOVEL, ORALLY-AVAILABLE PROTEASE INHIBITOR, AVL-181, DEMONSTRATING VIRAL CLEARANCE OFHEPATITIS C VIRUS IN PRE-CLINICAL MODELS.
Avila Therapeutics Inc (Avila) presented results of pre-clinical studies on its highly selective, small molecule Hepatitis C Virus...
unaggregatedarticle
Research on myeloma published by scientists at University of Copenhagen
"Maintenance therapy with interferon-alpha after high-dose treatment with stem cell support in multiple myeloma has been intensively debated....
unaggregatedarticle
J&J, Centocor Acquiring Egea For Protein Design Technology.
Staff Writer Just four years after Glen Evans left the academic world and founded his own company focused...
unaggregatedarticle
Other News To Note.
Advanced Biotherapy Inc., of Woodland Hills, Calif., reported publication in the June issue of the American Journal of...
unaggregatedarticle
Compugen and Bayer Schering Pharma to Collaborate on Compugen Discovered Oncology Target and Splice Variants.
Compugen Ltd. ( NASDAQ:CGEN ) announced that they have signed a collaboration agreement with Bayer Schering Pharma AG,...
unaggregatedarticle
Peregrine Pharmaceuticals Appoints Former Genentech Senior ExecutiveDr. Robert Garnick as Head of Regulatory Affairs.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHMD) announced that Dr. Robert Garnick has joined the company as the head of regulatory...
unaggregatedarticle
Enanta In-Licenses Chiron's HCV Protease Inhibitor Group.
Staff Writer In the field of hepatitis C virus (HCV) protease inhibitors, Enanta Pharmaceuticals Inc. now has added...
unaggregatedarticle
InterMune Begins Phase III Trial Of Once-Daily Infergen.
Washington Editor InterMune Inc. started a Phase III trial to evaluate the once-daily use of Infergen in combination...
unaggregatedarticle
Other News To Note.
o Alteon Inc., of Montvale, N.J., said its reverse stock split andits name change will go into effect...
unaggregatedarticle
Ambrx Licenses HGH Program To Merck Serono.
Staff Writer While wrapping up a Phase I/II trial with ARX201, Ambrx Inc. exclusively licensed the pegylated recombinant...
unaggregatedarticle
CuraGen, Seattle Genetics Form Cancer Deal Worth Up To $32M.
Washington Editor CuraGen Corp. licensed Antibody-Drug Conjugate technology from Seattle Genetics Inc. for use in developing antibodies in...
unaggregatedarticle
Compound Secures $12M Series A Round To Drive Adzyme Research.
Staff Writer Compound Therapeutics Inc. has hit the ground running after closing a $12 million Series A round...
unaggregatedarticle
1-20
of 947 related articles
1
2
3
4
5
6
7
8
9
10
Next
Press Releases
DelSite, Inc., Announces Third Quarter 2008 Earnings...
Research and Markets: Currently Druggable in Melanoma:...
Biovest Announces $1.6M in Federal Funding Appropriated...
How to Turn Your Business Dream into a Successful Reality
Napa Valley business owners tell Sumer Morenz of D&B Digital TV how they turned passion into bottom-line success.
Franchise Finder
Find your perfect franchise
Choose your location and industry and we'll show you the most relevant franchises.
Industry:
All Industries
Automotive Franchises
Business-to-Business Franchises
Children's Franchises
General Service Franchises
Health and Wellness Franchises
Home Service Franchises
Personal Care Franchises
Personal Finance Franchises
Pet Franchises
Restaurant and Food Franchises
Retail Franchises
Travel and Leisure Franchises
Location:
All Locations
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Worldwide
Africa
Asia
Australia/New Zealand
Canada
Central America
Europe
Mexico
Middle East
South America
Premium Content
It's a small world: first generation...
Polymers under one umbrella: Andrew Steward asks...
Therapeutic proteins; methods and protocols.(Brief...